Gaps Persist in Actual Versus Optimal Atherosclerotic Cardiovascular Disease Care
By Lori Solomon HealthDay Reporter
TUESDAY, Dec. 5, 2023 -- Roughly half of patients with atherosclerotic cardiovascular disease (ASCVD) adopt optimal prevention strategies across racial and ethnic subgroups, according to a study published online Dec. 1 in JAMA Network Open.
Yuan Lu, Sc.D., from Yale New Haven Hospital in Connecticut, and colleagues evaluated trends in racial and ethnic differences in utilization of guideline-recommended pharmacological medications and lifestyle modifications among U.S. adults with ASCVD. Analysis included data from 5,218 participants in the Health and Nutrition Examination Survey (1999 to 2020) with ASCVD.
The researchers found that over the study period, there was a significant increase in total cholesterol control and statin use in all racial and ethnic subgroups. Additionally, there were significant increases seen in angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use among non-Hispanic White and Hispanic and Latino individuals (Hispanic and Latino individuals: 17.12 percentage points; non-Hispanic White individuals: 12.14 percentage points). Smoking cessation increased significantly within the Hispanic and Latino population (−27.13 percentage points), as well as a lessening of the gap in smoking cessation between Hispanic and Latino individuals and White individuals (−24.85 percentage points). From 2017 to 2020, optimal regimens were used in 47.4 percent of Black, 48.7 percent of Hispanic and Latino, and 53.0 percent of White individuals.
"These results suggest that, despite efforts to enhance the quality of care for ASCVD patients, substantial disparities persist between current care and optimal care, underscoring the urgent need for ongoing initiatives to bridge these gaps and improve outcomes for all patients, regardless of their backgrounds," the authors write.
Several authors disclosed ties to the pharmaceutical and medical industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Apple Cider Vinegar Beneficial for Overweight, Obese Individuals
WEDNESDAY, March 13, 2024 -- For overweight and obese individuals, apple cider vinegar (ACV) consumption is associated with a significant reduction in anthropometric variables, as...
Dyslipidemia Raising Risk for CVD Among Young American Indians
TUESDAY, March 12, 2024 -- Dyslipidemia is associated with subclinical and clinical cardiovascular disease (CVD) among young American Indians, according to a study published...
2015 to 2021 Saw Marked Rise in PCSK9 Inhibitor Utilization
TUESDAY, March 5, 2024 -- Barriers for proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) use persist for cholesterol management, according to a research letter...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.